...
首页> 外文期刊>Pharmacogenomics >CuraGen Corporation
【24h】

CuraGen Corporation

机译:CuraGen公司

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

CuraGen Scientists have developed a deep preclinical pipeline of potential protein, antibody and small molecule therapeutics by integrating expertise in molecular biology with a proprietary suite of functional genomic technologies. One important application of functional genomics is in the area of pharmacogenomics, which has been a critical component in CuraGen's drug discovery and development efforts. By identifying safety and efficacy issues early in the discovery process and by gaining a better understanding of a drug's mechanism of action, CuraGen scientists are able to make more informed decisions about which drugs are the most appropriate to advance through the preclinical and clinical development stages.
机译:CuraGen科学家通过将分子生物学方面的专业知识与一组专有的功能基因组技术相结合,开发出了潜在的蛋白质,抗体和小分子治疗剂的深层临床前开发渠道。功能基因组学的一项重要应用是药物基因组学领域,它是CuraGen药物发现和开发工作中的关键组成部分。通过在发现过程的早期识别安全性和功效问题,并更好地了解药物的作用机制,CuraGen科学家能够就哪些药物最适合在临床前和临床开发阶段做出更明智的决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号